Blog — Insights & Updates

Regulatory AffairsApril 14, 2026 5 min

EU and UK Regulatory Submissions: Platforms, Authority Interactions and Timeline Control

Entering Europe after FDA approval? Learn how to manage EU and UK regulatory submissions, authority interactions, and submission timelines efficiently.

Read article

Regulatory AffairsClinicalApr 13, 2026 4 min

First-in-Human Operational Readiness for Emerging Biotechs: The Minimum Framework You Need

Prepare for First-in-Human trials with the right operational framework. Align safety, governance, and clinical execution to meet regulatory expectations.

Regulatory AffairsPharmacovigilanceApr 12, 2026 6 min

Operational Readiness for Europe: PV, QA and MAH Requirements Biotechs Cannot Ignore

Entering the EU market requires more than approval. Discover the pharmacovigilance, quality, and MAH requirements biotechs must prepare before European launch.

Qualification & ValidationApr 1, 2026 6 min

Utilities and Pharmaceutical Water Systems: A Hidden Compliance Risk Under Annex 1

Utilities such as pharmaceutical water systems and gases are often overlooked in Annex 1 remediation. Discover common compliance gaps and how to mitigate them.

ToxicologyQuality AssuranceApr 1, 2026 7 min

Extractables and Leachables (E&L): Reviewing the Current Regulatory Landscape

Extractables and leachables requirements are evolving with draft ICH Q3E. Learn how companies can prepare for future E&L regulatory expectations.

PharmacovigilanceMar 27, 2026 6 min

Scaling Pharmacovigilance Across Europe: Managing Local Requirements Without Losing Control

Expanding across Europe introduces complex pharmacovigilance requirements. Learn how EU PV systems can scale while integrating national roles and regulatory obligations.

PharmacovigilanceMar 25, 2026 5 min

AI in Pharmacovigilance: Efficiency Tool or Strategic Game-Changer?

AI is transforming pharmacovigilance processes from case processing and literature monitoring to signal detection. Discover how AI and NLP can enhance efficiency, compliance, and regulatory intelligence.

Regulatory AffairsMar 25, 2026 4 min

From R&D to Market: Why the Product Lifecycle Is the Strategic Framework for MedTech

Successful MedTech companies treat product development as a lifecycle strategy. Learn why regulatory planning, IP strategy and development must evolve together.

Regulatory AffairsMar 24, 2026 3 min

SaMD Under EU MDR: What Software Developers Need to Know

Developing Software as a Medical Device under EU MDR requires clear intended use, risk classification under Rule 11, and compliance with IEC 62304. Learn what SaMD developers need to know.

Regulatory AffairsMar 23, 2026 4 min

IP Strategy for MedTech Startups: What Early-Stage Companies Often Miss

IP strategy should start early in MedTech development. Discover how patent strategy, regulatory classification, and product development influence IP protection for emerging MedTech companies.

Regulatory AffairsMar 22, 2026 5 min

EU MDR Compliance for MedTech Startups: What It Really Takes

EU MDR compliance can be challenging for emerging MedTech companies. Learn what MDR actually requires, from qualification and QMS to technical documentation and post-market obligations.

Regulatory AffairsMar 21, 2026 4 min

3 Things MedTech Startups Get Wrong About IP & Regulatory Strategy

Many MedTech startups treat IP and regulatory strategy as separate disciplines. Discover the three most common mistakes and how aligning both early strengthens market access and product value.

Regulatory AffairsMar 4, 2026 4 min

Scientific Advice for Startups: Turning the Right Questions into Regulatory Clarity

Scientific Advice is one of the few moments in early development where a biotech can test its assumptions with regulators. Learn how to structure questions, integrate CMC and clinical strategy, and leverage EMA SME support for maximum impact.